Ripasudil Eyedrops Ameliorated Bullous Keratopathy Complicated with Cytomegalovirus Corneal Endotheliitis: A Case Report

Ocul Immunol Inflamm. 2023 Jan;31(1):207-210. doi: 10.1080/09273948.2021.1988114. Epub 2021 Nov 2.

Abstract

Purpose: We describe a case of bullous keratopathy complicated with cytomegalovirus (CMV) corneal endotheliitis that was successfully treated with ripasudil eye drops.

Methods: A retrospective case report.

Results: A 65-year-old female patient diagnosed with CMV-associated anterior uveitis in the right eye was referred to us when anterior uveitis recurred with bullous keratopathy. Initial best-corrected visual acuity (BCVA) was 0.4 (decimal visual acuity). Her condition did not improve with anti-CMV treatment, and BCVA decreased to 0.07. At this point, intraocular pressure (IOP) was 20 mmHg, and ripasudil eye drops were started for IOP control. After 1 month, not only had IOP decreased to 14 mm Hg but the condition of the corneal edema had also improved. The central corneal thickness decreased to a normal level, and the BCVA recovered to 0.8.

Conclusion: Ripasudil eye drops not only lower IOP in patients with CMV corneal endotheliitis but may also have the potential to treat bullous keratopathy.

Keywords: Bullous keratopathy; Corneal endotheliitis; cytomegalovirus; ripasudil; rock inhibitors.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Corneal Edema* / diagnosis
  • Corneal Edema* / drug therapy
  • Corneal Edema* / etiology
  • Cytomegalovirus / genetics
  • Cytomegalovirus Infections* / complications
  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus Infections* / drug therapy
  • DNA, Viral
  • Endothelium, Corneal
  • Eye Infections, Viral* / complications
  • Eye Infections, Viral* / diagnosis
  • Eye Infections, Viral* / drug therapy
  • Female
  • Humans
  • Keratitis* / complications
  • Keratitis* / diagnosis
  • Keratitis* / drug therapy
  • Ophthalmic Solutions
  • Retrospective Studies
  • Uveitis, Anterior*

Substances

  • K-115
  • Ophthalmic Solutions
  • DNA, Viral